SHC: Sterigenics Market Cap to Earnings

Sterigenics - graphic logo of issuer SHC

Sotera Health Company (SHC) provides sterilization of instruments and containers for global corporations under reliable contracts. The company's weighted average P/E reflects market value dynamics, where 28.00 is recorded as the baseline value. A wide range of services and international reach serve as a defensive asset, while the capacity scaling strategy for processing centers ensures growth within the expanding pharmaceutical market.

Sotera Health (SHC) P/E Multiple: for the period 07/04/2022 - 11/15/2026

Analytical breakdowns for Sotera Health Company

- stock quotes and analyst forecast:
- market capitalization information:
Comprehensive company analysis:SHC (Sterigenics)
Manufactured product of Sotera Health Company

The P/E ratio reflects the market value of one dollar of net income, determining the premium for strategic control and future business growth rates. An analysis of the company's valuation via P/E allows for a correlation between the current multiple and the fundamental stability of Sotera Health Company (SHC), whose position is strengthened by stringent FDA standards and high switching costs for customers moving to other sterilization operators.

Competing companies

Agilent (A) - Business Payback Period|Price to Earnings Ratio DGX (questdiagnostics.com)|Price to Earnings Ratio ILMN (Illumina, Inc.)|Exact Sciences Corp - Price to Earnings Ratio|revvity.com (RVTY) - Market Cap to Earnings|Bio-Rad Laboratories, Inc. - P/E Multiple|Business Payback Period Anbio NNNN|QDEL: P/E Multiple|OPK - Business Payback Period|Price to Earnings Ratio CareDx|maravai.com (MRVI) - Business Payback Period|P/E Multiple FLGT|Market Price to Net Income Ratio LAB|cytekbio.com - Price to Earnings Ratio|Company Value to Net Income OSUR|exagen.com - P/E Multiple|MDXH (MDxHealth SA) - Price to Earnings Multiple|LUCD: P/E Multiple|Market Cap to Earnings Prenetics Global (PRE)|IMDX (Insight Molecular Diagnostics) - P/E Multiple|Trinity Biotech (TRIB) - Business Payback Period|P/E Multiple PRPH|AIMD (Ainos, Inc.) - Company Value to Net Income|P/E Multiple CODX (codiagnostics.com)|Market Price to Net Income Ratio HSCS (HeartSciences)|Biomerica Inc - P/E Multiple|CDIO (cardiodiagnosticsinc.com) - Price to Earnings Multiple|ONCO (Onconetix) - Price to Earnings Ratio|Market Cap to Earnings viraxbiolabs.com (VRAX)|BJDX (Bluejay Diagnostics Inc) - P/E Multiple|Market Cap to Earnings Aspira Women's Health, Inc. AWH|Price to Earnings Ratio AXDX (Accelerate Diagnostics, Inc)|CENTOGENE, N.V. - Price to Earnings Multiple|Enzo Biochem, Inc. - Price to Earnings Ratio|FRES - Price to Earnings Ratio|GENE - Price to Earnings Ratio|Company Value to Net Income ME (23andMe)|PMD: P/E Multiple